4.6 Review

Adaptive immune regulation in autoimmune diabetes

Journal

AUTOIMMUNITY REVIEWS
Volume 15, Issue 3, Pages 236-241

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2015.11.008

Keywords

Type 1 diabetes; Regulatory T-cell immunotherapy; beta-Cells

Categories

Ask authors/readers for more resources

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the loss of insulin-producing pancreatic beta-cells. The pathogenesis of T1D is complex and multifactorial and involves a genetic susceptibility that predisposes to abnormal immune responses in the presence of ill-defined environmental insults to the pancreatic islets. This review discusses how adaptive immunoregulatory T cells contribute to the modulation of the development and evolution of T1D, together with potential approaches that target these cells for new therapies in the disease. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available